[]

X X Shen1, J P Yu1, R Guo1

  • 1Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China.

概括

在新诊断的多发性骨髓瘤 (NDMM) 患者中,mSMART 4.0系统提供了更精确的高风险细胞遗传异常 (HRCAs) 定义. 与mSMART 3.0.0相比,该系统可以更好地区分预后风险.